Keywords: solvay, files, pulzium, iv, fda, belgian, drugmaker

Solvay files Pulzium IV with US FDA

Article | 30 April 2007

Print This

Belgian drugmaker Solvay says that its dossier for Pulzium IV (intravenous tedisamil), a New Chemical Entity developed in-house, has been ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in